• Je něco špatně v tomto záznamu ?

Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation

V. Radochová, M. Šembera, R. Slezák, O. Heneberk, J. Radocha

. 2021 ; 10 (24) : . [pub] 20211210

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001068

Grantová podpora
PROGRES Q40/13 Charles University
MH CZ - DRO (UHHK, 00179906) University Hospital Hradec Králové

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) can induce serious oral complications, including oral mucositis (OM). The presence of periodontal inflammation before HSCT is believed to be associated with OM. The aim of our study was to determine the prevalence and severity of OM in patients undergoing HSCT and its relation to periodontal status. PATIENTS AND METHODS: This is a retrospective study of patients who underwent HSCT and a detailed dental examination between 2007 and 2015. The dental and periodontal status of all patients was evaluated by clinical and radiographic examination prior to HSCT. Oral health was assessed with the gingival index, the the community periodontal index, presence of plaque-related gingivitis, and marginal periodontitis. During the HSCT period, patients were examined daily for the presence of OM, which was graded according to World Health Organization (WHO) classification if present. The patients were assigned to the groups according to type of transplantation: autologous HSCT, myeloablative allogeneic HSCT, and non-myeloablative allogeneic HSCT. RESULTS: A total of 496 patients were included in the study. OM was present in 314 of 496 patients (63.3%): 184/251 (73.3%) in the autologous group, 100/151 (66.2%) in the myeloablative allogeneic group, and 30/94 (31.9%) in the nonmyeloablative allogeneic group. Significantly more patients suffered from OM in the autologous and myeloablative groups versus the nonmyeloablative conditioning group (p < 0.001). The presence of periodontal inflammation did not significantly differ among the groups. There was only a borderline trend for the higher prevalence of OM in the non-myeloablative allogeneic nonmyeloablative group when periodontal inflammation was present (0.073939). CONCLUSIONS: Oral mucositis prevalence and severity after stem cell transplantation is not widely affected by the oral hygiene and periodontal disease presence before HSCT. We confirmed the wide-known connection of the conditioning regimen intensity to the prevalence of OM.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001068
003      
CZ-PrNML
005      
20220112153455.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm10245790 $2 doi
035    __
$a (PubMed)34945086
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Radochová, Vladimíra $u Department of Dentistry, University Hospital in Hradec Králové, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic
245    10
$a Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation / $c V. Radochová, M. Šembera, R. Slezák, O. Heneberk, J. Radocha
520    9_
$a BACKGROUND: Hematopoietic stem cell transplantation (HSCT) can induce serious oral complications, including oral mucositis (OM). The presence of periodontal inflammation before HSCT is believed to be associated with OM. The aim of our study was to determine the prevalence and severity of OM in patients undergoing HSCT and its relation to periodontal status. PATIENTS AND METHODS: This is a retrospective study of patients who underwent HSCT and a detailed dental examination between 2007 and 2015. The dental and periodontal status of all patients was evaluated by clinical and radiographic examination prior to HSCT. Oral health was assessed with the gingival index, the the community periodontal index, presence of plaque-related gingivitis, and marginal periodontitis. During the HSCT period, patients were examined daily for the presence of OM, which was graded according to World Health Organization (WHO) classification if present. The patients were assigned to the groups according to type of transplantation: autologous HSCT, myeloablative allogeneic HSCT, and non-myeloablative allogeneic HSCT. RESULTS: A total of 496 patients were included in the study. OM was present in 314 of 496 patients (63.3%): 184/251 (73.3%) in the autologous group, 100/151 (66.2%) in the myeloablative allogeneic group, and 30/94 (31.9%) in the nonmyeloablative allogeneic group. Significantly more patients suffered from OM in the autologous and myeloablative groups versus the nonmyeloablative conditioning group (p < 0.001). The presence of periodontal inflammation did not significantly differ among the groups. There was only a borderline trend for the higher prevalence of OM in the non-myeloablative allogeneic nonmyeloablative group when periodontal inflammation was present (0.073939). CONCLUSIONS: Oral mucositis prevalence and severity after stem cell transplantation is not widely affected by the oral hygiene and periodontal disease presence before HSCT. We confirmed the wide-known connection of the conditioning regimen intensity to the prevalence of OM.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šembera, Martin $u Department of Dentistry, University Hospital in Hradec Králové, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Slezák, Radovan $u Department of Dentistry, University Hospital in Hradec Králové, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Heneberk, Ondřej $u Department of Dentistry, University Hospital in Hradec Králové, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Radocha, Jakub $u 4th Department of Internal Medicine-Hematology, University Hospital in Hradec Králové, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 10, č. 24 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34945086 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153451 $b ABA008
999    __
$a ind $b bmc $g 1745350 $s 1152215
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 10 $c 24 $e 20211210 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
GRA    __
$a PROGRES Q40/13 $p Charles University
GRA    __
$a MH CZ - DRO (UHHK, 00179906) $p University Hospital Hradec Králové
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace